Fresenius SE & Co. KGaA (FSNUY)

OTC Markets OTCPK • Currently up 0.10 (+0.69%) in today's trading session

1 member of Congress has disclosed 1 trade in Fresenius SE & Co. KGaA (FSNUY) via STOCK Act filings. The most recent disclosure was a sale by Greg Gianforte on 21 December 2018. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).

Fresenius SE & Co. KGaA is currently trading at $14.52, positioned at 75% of its 52-week range ($10.33 – $15.94).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$14.52
24h Change
+0.10 (+0.69%)
52 Week Range
$10.33–$15.94
View on NASDAQ

Fresenius SE & Co. KGaA Price History and Technical Analysis

Congressional Trading Activity for FSNUY

Select to highlight on chart
1 transactions
Compliance: 100%
Greg Gianforte21 Dec 201823 Jan 2019SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$130.85B

Volume

16.22K

Beta

0.83

P/E Ratio

14.67

Fundamentals

EPS

$0.99

Div. Yield

2.10%

Open

$14.32

Day Range

$14.32 – $14.62

Company Information

Sector
Healthcare
Industry
Medical - Care Facilities
Exchange
OTC · USD
Country
DE
CEO
Michael Sen
IPO Date
2012-05-15
Website
www.fresenius.com

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius...

Earnings

Next Report

Q4 2026

24 Feb

EPS Est.

$0.25

Rev. Est.

$7.1B

Days Until

107

Recent Quarters

Q3 20264 Nov
EPS$0.25
Beat 16.0%
Q2 20265 Aug
EPS$0.24
Miss 4.0%
Q1 20266 May
EPS$0.24
Miss 5.3%
Q4 202525 Feb
EPS$0.28
Beat 4.1%
Q3 20255 Nov
EPS$0.23
Beat 10.6%
Q2 20256 Aug
EPS$0.24
Beat 10.0%
Q1 20257 May
EPS$0.23
Beat 9.9%
Q4 202426 Feb
EPS$0.18
Miss 0.6%
Q3 20246 Nov
EPS$0.19
Beat 7.5%
Q2 202431 Jul
EPS$0.22
Beat 15.6%
Q1 20248 May
EPS$0.20
Beat 5.9%
Q4 202321 Feb
EPS$0.19
Miss 5.6%
Q3 20232 Nov
EPS$0.17
Beat 3.6%
Q2 20232 Aug
EPS$0.18
Beat 2.9%
Q1 20239 May
EPS$0.19
Beat 13.1%
Q4 202221 Feb
EPS$0.20
Miss 14.8%
Q3 202230 Oct
EPS$0.14
Miss 16.7%
Q2 20222 Aug
EPS$0.21
Beat 0.2%
Q1 20224 May
EPS$0.23
Beat 7.5%
Q4 202122 Feb
EPS$0.27
Beat 5.3%
Q3 20212 Nov
EPS$0.22
Q2 202130 Jul
EPS$0.26
Q1 20216 May
EPS$0.24
Q4 202023 Feb
EPS$0.26
Q3 202029 Oct
EPS$0.22
Q2 202030 Jul
EPS$0.20
Q1 20206 May
EPS$0.23
Q4 201919 Feb
EPS$0.25
Q3 201929 Oct
EPS$0.22
Q2 201931 Jul
EPS$0.24
Q1 20192 May
EPS$0.25
Q4 201819 Feb
EPS$0.25
Q3 201831 Oct
EPS$0.23
Q2 20181 Aug
EPS$0.35
Q1 20184 May
EPS$0.26
Q4 201726 Feb
EPS$0.26
Q3 20173 Nov
EPS$0.21
Q2 20173 Aug
EPS$0.22
Q1 20173 May
EPS$0.22
Q4 201622 Feb
EPS$0.22
Q3 201627 Oct
EPS$0.73
Beat 0.0%
Q2 20162 Aug
EPS$0.71
Beat 1.4%
Q1 20163 May
EPS$0.66
Beat 3.1%
Q4 201524 Feb
EPS$0.73
Miss 1.4%
Q3 201529 Oct
EPS$0.65
Beat 3.2%
Q2 201530 Jul
EPS$0.64
Beat 8.5%
Q1 201529 Apr
EPS$0.54
Beat 22.7%
Q4 201425 Feb
EPS$0.48
Miss 17.2%
Q3 20144 Nov
EPS$0.52
Miss 38.8%
Q2 201431 Jul
EPS$1.42
Miss 4.7%
Q1 201412 May
EPS$1.37
Beat 5.4%
Q4 201325 Feb
EPS$2.26
Miss 5.8%
Q3 201331 Dec
EPS$0.70
Q1 201330 Jun
EPS$0.58
Q4 201231 Mar
EPS$0.52
Q3 201231 Dec
EPS$0.58
Q2 201230 Sept
EPS$0.58
Q1 201230 Jun
EPS$0.97
Q4 201131 Mar
EPS$1.22
Q3 201131 Dec
EPS$1.06
Q2 201130 Sept
EPS$1.07
Q1 201130 Jun
EPS$0.80
Q4 201031 Mar
EPS$0.76
Q3 201031 Dec
EPS$0.96
Q2 201030 Sept
EPS$0.96
Q1 201030 Jun
EPS$0.75
Q4 200931 Mar
EPS$0.57
Q3 200931 Dec
EPS$0.87
Q2 200930 Sept
EPS$0.58
Q1 200930 Jun
EPS$0.68
Q4 200831 Mar
EPS$0.77

Dividends

Dividend History

26 May 2026
Amount $0.3048
27 May 2025
Amount $0.2830
18 May 2023
Amount $0.2470
16 May 2022
Amount $0.2420
24 May 2021
Amount $0.2670
31 Aug 2020
Amount $0.2380
20 May 2019
Amount $0.2250
21 May 2018
Amount $0.2300
15 May 2017
Amount $0.1640
11 May 2016
Amount $0.1550
18 May 2015
Amount $0.1230
14 May 2014
Amount $0.1433
15 May 2013
Amount $0.1193

Stock Splits

Split History

5 Aug 2014Stock Split
Ratio3:2

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about FSNUY

Which members of Congress have traded FSNUY?
1 member of Congress has disclosed 1 trade in Fresenius SE & Co. KGaA (FSNUY) under the STOCK Act: Greg Gianforte.
When was FSNUY most recently disclosed by Congress?
The most recent FSNUY disclosure was a sale by Greg Gianforte on 21 December 2018.
What is the total disclosed congressional trading volume for FSNUY?
Members of Congress have disclosed approximately $8K in FSNUY sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in FSNUY?
This FSNUY page updates as soon as new STOCK Act disclosures are filed for Fresenius SE & Co. KGaA. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.